Innovation Pharmaceuticals Inc (IPIX)

[zandant]

So we find out today that Brilacidin failed as a potential vaccine so that avenue is now closed. Curious as to when Ehrlich found out that Brilacidin was not a viable vaccine candidate? And why would the vaccine pathway remain of interest?

The prophylactic use of B in vitro sounds promising but as we all know, many drugs look good in a test tube or dish but don’t have the same effect in the human body. Still in the game though. As for the 16 hour post infection experiment, can someone better versed in these experiments explain why a number was attached to the prophylactic experiment but when it came to the therapeutic experiment, only a “dose-dependent reduction” was reported by the company?.